Molecular determinant deciphering of MIC-guided RND efflux substrates in E. coli
Open Access
- 8 March 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Drug Discovery
- Vol. 4, 1326121
Abstract
Antimicrobial resistance poses an urgent and formidable global public health threat. The escalation of bacterial multidrug resistance to antibiotics has the potential to become a leading cause of global mortality if there is no substantial improvement in antimicrobial development and therapy protocols. In light of this, it is imperative to identify the molecular determinants responsible for the reduced antibiotic activity associated with RND efflux pumps. This comprehensive study meticulously examines Minimum Inhibitory Concentration (MIC) data obtained from in vitro tests for various antibiotic families and non-active dye compounds, sourced from diverse literature references. The primary focus of this study is to assess the susceptibility of these agents to efflux-resistant Escherichia coli strains, integrating both MIC data and relevant physicochemical properties. The central objective is to unveil the specific substituents that significantly influence the uptake process mediated by the AcrAB-TolC efflux system. This exploration seeks to reveal the consequences of these substituents on pharmacodynamic responses, providing valuable insights into Structure-Activity Relationships. It is noteworthy that this analysis represents a pioneering effort, with prospective implications for RND efflux pump-producing strains. Ultimately, deciphering efflux markers is crucial to effectively mitigate the emergence of specific resistance and to better monitor the role of this primary resistance mechanism in Gram-negative bacteria, particularly as observed in clinical antibiotic therapy practice.Keywords
This publication has 128 references indexed in Scilit:
- Quinolone: a versatile therapeutic compound classMolecular Diversity, 2022
- Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic DrugsChemistry – A European Journal, 2020
- Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and PersistenceJournal of Molecular Evolution, 2019
- Recent updates of fluoroquinolones as antibacterial agentsArchiv der Pharmazie, 2018
- Genetic basis of enzymatic resistance of E. coli to aminoglycosidesAdvances in Medical Sciences, 2018
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative BacilliDrugs, 2013
- Exploiting bacterial DNA gyrase as a drug target: current state and perspectivesApplied Microbiology and Biotechnology, 2011
- Saline and buffers minimize the action of interfering factors in the bacterial endotoxins testAnalytical Biochemistry, 2011
- Sample stacking for the analysis of penicillins by microemulsion electrokinetic chromatographyElectrophoresis, 2008
- Lipophilicity of antibacterial fluoroquinolonesInternational Journal of Pharmaceutics, 1992